Development
D
Hydreight Technologies Inc. NURS.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2023 06/30/2023 03/31/2023 12/31/2022 09/30/2022
Revenue 227.86% 256.93% 268.90% 230.27% --
Total Other Revenue -- -- -- -- --
Total Revenue 227.86% 256.93% 268.90% 230.27% --
Cost of Revenue 272.20% 280.76% 297.40% 326.71% --
Gross Profit 180.67% 229.70% 239.54% 154.42% --
SG&A Expenses 142.02% 180.92% 210.86% 151.13% --
Depreciation & Amortization 142.60% 557.97% -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 195.17% 224.36% 249.16% 209.80% --
Operating Income -70.92% -99.48% -162.29% -153.95% --
Income Before Tax -373.25% -450.41% -565.07% -1,133.31% --
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -368.86% -444.25% -555.77% -1,104.62% --
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -368.86% -444.25% -555.77% -1,104.62% --
EBIT -70.92% -99.48% -162.29% -153.95% --
EBITDA -170.85% -334.21% -- -- --
EPS Basic -- -- -- -- --
Normalized Basic EPS -- -- -- -- --
EPS Diluted -- -- -- -- --
Normalized Diluted EPS -- -- -- -- --
Average Basic Shares Outstanding -- -- -- -- --
Average Diluted Shares Outstanding -- -- -- -- --
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --